Annual CFF
$1.11 M
-$766.00 K-40.88%
December 31, 2023
Summary
- As of February 7, 2025, CLGN annual cash flow from financing activities is $1.11 million, with the most recent change of -$766.00 thousand (-40.88%) on December 31, 2023.
- During the last 3 years, CLGN annual CFF has fallen by -$3.36 million (-75.18%).
- CLGN annual CFF is now -97.14% below its all-time high of $38.76 million, reached on December 31, 2021.
Performance
CLGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, CLGN quarterly cash flow from financing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, CLGN quarterly CFF has dropped by -$216.00 thousand (-100.00%).
- CLGN quarterly CFF is now -100.00% below its all-time high of $35.51 million, reached on March 1, 2021.
Performance
CLGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$9000.00
-$216.00 K-96.00%
September 30, 2024
Summary
- As of February 7, 2025, CLGN TTM cash flow from financing activities is $9000.00, with the most recent change of -$216.00 thousand (-96.00%) on September 30, 2024.
- Over the past year, CLGN TTM CFF has dropped by -$1.50 million (-99.40%).
- CLGN TTM CFF is now -99.98% below its all-time high of $38.76 million, reached on December 1, 2021.
Performance
CLGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CLGN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.9% | -100.0% | -99.4% |
| 3 y3 years | -75.2% | -100.0% | -99.4% |
| 5 y5 years | -59.8% | -100.0% | -99.4% |
CLGN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.1% | at low | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -97.1% | at low | -100.0% | +100.0% | -100.0% | at low |
| alltime | all time | -97.1% | +9451.7% | -100.0% | +100.0% | -100.0% | +116.0% |
CollPlant Biotechnologies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $9000.00(-96.0%) |
| Jun 2024 | - | $0.00(-100.0%) | $225.00 K(-28.3%) |
| Mar 2024 | - | $9000.00(>+9900.0%) | $314.00 K(-71.7%) |
| Dec 2023 | $1.11 M(-40.9%) | $0.00(-100.0%) | $1.11 M(-26.5%) |
| Sep 2023 | - | $216.00 K(+142.7%) | $1.51 M(+16.7%) |
| Jun 2023 | - | $89.00 K(-88.9%) | $1.29 M(+7.4%) |
| Mar 2023 | - | $803.00 K(+100.8%) | $1.20 M(-35.8%) |
| Dec 2022 | $1.87 M(-95.2%) | $400.00 K(>+9900.0%) | $1.87 M(+16.0%) |
| Sep 2022 | - | $0.00(0.0%) | $1.62 M(-51.9%) |
| Jun 2022 | - | $0.00(-100.0%) | $3.36 M(-28.8%) |
| Mar 2022 | - | $1.47 M(+938.0%) | $4.72 M(-87.8%) |
| Dec 2021 | $38.76 M(+768.1%) | - | - |
| Dec 2021 | - | $142.00 K(-91.9%) | $38.76 M(+0.4%) |
| Sep 2021 | - | $1.75 M(+28.6%) | $38.61 M(+4.7%) |
| Jun 2021 | - | $1.36 M(-96.2%) | $36.88 M(+4.0%) |
| Mar 2021 | - | $35.51 M(<-9900.0%) | $35.47 M(+694.4%) |
| Dec 2020 | $4.46 M(-17.5%) | - | - |
| Dec 2020 | - | -$6000.00(-137.5%) | $4.46 M(0.0%) |
| Sep 2020 | - | $16.00 K(-129.6%) | $4.46 M(-54.8%) |
| Jun 2020 | - | -$54.00 K(-101.2%) | $9.88 M(-0.6%) |
| Mar 2020 | - | $4.51 M(<-9900.0%) | $9.94 M(+83.7%) |
| Dec 2019 | $5.41 M | - | - |
| Dec 2019 | - | -$6000.00(-100.1%) | $5.41 M(+1.6%) |
| Sep 2019 | - | $5.43 M(>+9900.0%) | $5.33 M(+343.0%) |
| Jun 2019 | - | $3000.00(-114.3%) | $1.20 M(-45.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$21.00 K(-76.9%) | $2.22 M(-19.4%) |
| Dec 2018 | $2.75 M(-69.8%) | - | - |
| Dec 2018 | - | -$91.00 K(-106.9%) | $2.75 M(-61.0%) |
| Sep 2018 | - | $1.31 M(+28.7%) | $7.06 M(-8.3%) |
| Jun 2018 | - | $1.02 M(+98.2%) | $7.69 M(-0.9%) |
| Mar 2018 | - | $514.00 K(-87.8%) | $7.76 M(-14.7%) |
| Dec 2017 | $9.11 M(+89.5%) | - | - |
| Dec 2017 | - | $4.21 M(+116.4%) | $9.11 M(+90.9%) |
| Sep 2017 | - | $1.95 M(+78.4%) | $4.77 M(+61.5%) |
| Jun 2017 | - | $1.09 M(-41.2%) | $2.95 M(-37.4%) |
| Mar 2017 | - | $1.86 M(-1608.9%) | $4.72 M(-1.9%) |
| Dec 2016 | $4.81 M(+86.9%) | - | - |
| Dec 2016 | - | -$123.00 K(-194.8%) | $4.81 M(-2.8%) |
| Sep 2016 | - | $129.70 K(-95.5%) | $4.95 M(-32.8%) |
| Jun 2016 | - | $2.85 M(+46.6%) | $7.36 M(+63.0%) |
| Mar 2016 | - | $1.95 M(>+9900.0%) | $4.52 M(+75.7%) |
| Dec 2015 | $2.57 M(>+9900.0%) | - | - |
| Dec 2015 | - | $16.70 K(-99.3%) | $2.57 M(+3.2%) |
| Sep 2015 | - | $2.55 M(>+9900.0%) | $2.49 M(-4532.7%) |
| Jun 2015 | - | $7100.00(-111.2%) | -$56.20 K(-110.5%) |
| Dec 2014 | $11.60 K(-99.9%) | - | - |
| Dec 2014 | - | -$63.30 K(-110.5%) | $537.10 K(-10.5%) |
| Jun 2014 | - | $600.40 K | $600.40 K |
| Dec 2013 | $7.87 M(+126.3%) | - | - |
| Dec 2012 | $3.48 M | - | - |
FAQ
- What is CollPlant Biotechnologies annual cash flow from financing activities?
- What is the all time high annual CFF for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies annual CFF year-on-year change?
- What is CollPlant Biotechnologies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies quarterly CFF year-on-year change?
- What is CollPlant Biotechnologies TTM cash flow from financing activities?
- What is the all time high TTM CFF for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies TTM CFF year-on-year change?
What is CollPlant Biotechnologies annual cash flow from financing activities?
The current annual CFF of CLGN is $1.11 M
What is the all time high annual CFF for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high annual cash flow from financing activities is $38.76 M
What is CollPlant Biotechnologies annual CFF year-on-year change?
Over the past year, CLGN annual cash flow from financing activities has changed by -$766.00 K (-40.88%)
What is CollPlant Biotechnologies quarterly cash flow from financing activities?
The current quarterly CFF of CLGN is $0.00
What is the all time high quarterly CFF for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high quarterly cash flow from financing activities is $35.51 M
What is CollPlant Biotechnologies quarterly CFF year-on-year change?
Over the past year, CLGN quarterly cash flow from financing activities has changed by -$216.00 K (-100.00%)
What is CollPlant Biotechnologies TTM cash flow from financing activities?
The current TTM CFF of CLGN is $9000.00
What is the all time high TTM CFF for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high TTM cash flow from financing activities is $38.76 M
What is CollPlant Biotechnologies TTM CFF year-on-year change?
Over the past year, CLGN TTM cash flow from financing activities has changed by -$1.50 M (-99.40%)